RxDoctor Payments Data

Michelle Golden

Physician Assistant · Bear, DENPI 1104339852

Payments from drug & device makers

$1,898in general payments, 2019–2025

Across 104 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$244
  • AbbVie$162
  • Lilly USA, LLC$155
  • Indivior Inc.$150
  • Exact Sciences$141
  • Abbott$108
  • plus $939 from 23 others

What the payments were for

  • Food & beverage$1,898100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,898 in reported general payments places this provider in the 85th percentile of 527 physician assistant providers in Delaware.

See all physician assistant providers in Delaware

Medicare billing

Part B allowed, 2024
$33,126
Medicare patients
171
Services billed
421

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin17$30,647
TrulicityDulaglutide13$21,664
OzempicSemaglutide15$21,128
Rosuvastatin Calcium48$1,962
Atorvastatin Calcium95$827
Albuterol Sulfate HfaAlbuterol Sulfate26$698
Losartan Potassium72$662
Omeprazole48$634
Amlodipine Besylate68$523
Hydroxyzine Hcl22$509
Gabapentin29$387
Metformin Hcl70$372
Triamcinolone Acetonide30$337
Lisinopril43$317
Levothyroxine Sodium44$314

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$15$30,64717 claims
Lilly USA, LLCTrulicity$155$21,66413 claims
Novo NordiskOzempic$46$21,12815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 527 physician assistant providers in Delaware.

Other physician assistant in Bear

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →